We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

110 hedge funds and large institutions have $648M invested in Fulcrum Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more call options, than puts

Call options by funds: $2.24M | Put options by funds: $1.22M

78% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 23

42% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 24

9% more funds holding

Funds holding: 101110 (+9)

1.65% more ownership

Funds ownership: 92.98%94.63% (+1.6%)

36% less capital invested

Capital invested by funds: $1.01B → $648M (-$362M)

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
110
Holders Change
+9
Holders Change %
+8.91%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
34
Increased
41
Reduced
23
Closed
24
Calls
$2.24M
Puts
$1.22M
Net Calls
+$1.02M
Net Calls Change
+$1.92M
Name Holding Trade Value Shares
Change
Change in
Stake
CG
101
Cutler Group
California
$15K
SOW
102
State of Wyoming
Wyoming
$13K +$14.8K +749 New
SGAM
103
Smith Group Asset Management
Texas
$9K
PCH
104
Polar Capital Holdings
United Kingdom
$8.85K -$4.95M -250,000 -33%
National Bank of Canada
105
National Bank of Canada
Quebec, Canada
$8K +$9.11K +460 New
PP
106
PrairieView Partners
Minnesota
$4K +$3.96K +200 New
Daiwa Securities Group
107
Daiwa Securities Group
Japan
$2K
Manulife (Manufacturers Life Insurance)
108
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$254 +$6.62K +334 +2%
CAC
109
Cowen and Company
New York
-$44M -1,560,563 Closed
BC
110
Boxer Capital
California
-$35.3M -1,250,000 Closed
N
111
Natixis
France
-$7.11M -250,000 Closed
SCM
112
Silverarc Capital Management
Massachusetts
-$5.24M -185,691 Closed
PIM
113
Platinum Investment Management
Australia
-$4.29M -152,186 Closed
Renaissance Technologies
114
Renaissance Technologies
New York
-$3.78M -133,900 Closed
EGI
115
EAM Global Investors
California
-$2.21M -78,384 Closed
SFI
116
Susquehanna Fundamental Investments
Pennsylvania
-$1.63M -57,726 Closed
EI
117
EAM Investors
California
-$1.56M -55,383 Closed
GTC
118
Ghost Tree Capital
New York
-$1.41M -50,000 Closed
Voloridge Investment Management
119
Voloridge Investment Management
Florida
-$861K -30,533 Closed
LP
120
LMR Partners
United Kingdom
-$846K -30,000 Closed
Verition Fund Management
121
Verition Fund Management
Connecticut
-$564K -20,000 Closed
CAM
122
ClariVest Asset Management
California
-$556K -19,700 Closed
MGB
123
Mass General Brigham
Massachusetts
-$447K -15,860 Closed
PP
124
PDT Partners
New York
-$381K -13,523 Closed
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
-$325K -11,501 Closed

FULC Hedge Fund Activity: Q4 2021 in Review

110 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q4 2021, worth a combined $648M — down 36% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new FULC positions and 24 closed out — a net gain of 10 holders — while 41 added to existing stakes and 23 trimmed.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $17.1M. The largest seller was Cowen and Company, exiting entirely with an estimated $44M sold.

  • 110 institutional investors held Fulcrum Therapeutics (FULC) as of Q4 2021, up from 101 in Q3 2021.
  • Funds reported $648M of Fulcrum Therapeutics stock for Q4 2021, down 36% quarter-over-quarter.
  • 34 funds opened new Fulcrum Therapeutics positions in Q4 2021 and 24 closed out, a net change of +10 holders.
  • The largest Fulcrum Therapeutics buyer in Q4 2021 was Holocene Advisors, an estimated $17.1M added.
  • The largest Fulcrum Therapeutics seller in Q4 2021 was Cowen and Company, an estimated $44M sold.

Based on aggregated 13F filings for Q4 2021.